Using Nanotechnology Structured Water to Control Blood Glucose in Type 2 Diabetic Patients.

Study Overview
=================
Brief Summary
-----------------
Type 2 DM is due to insulin resistance or low insulin secretion or sometimes a combination of both. Nanotechnology structured water is a type of water that is produced using energy field modulators to change the biological, chemical, and physical properties of water molecules and improve the bioavailability of this nano-water. Objective: To find out the effect of drinking nanotechnology structured water (Magnalife®) on the blood glucose levels in patients with type 2 diabetes mellitus.

Detailed Description
-----------------
This is a blind randomized control trial, according to CONSORT guidelines for randomization, Participants were randomly assigned following simple randomization procedures (computerized random numbers) to 1 of 2 treatment groups., that included 387 patients with Type 2 diabetes mellitus in Diabetes Care Center, Sulaymaniyah, Kurdistan region from July 2016 till February 2018. A total of 387 patients with type 2 diabetes who were patients in this center and agreed to participate in this clinical trial were included in this study. In group A, patients were given nanotechnology structured water Magnalife® and in group B they were given ordinary bottled drinking water as a control . The bottles were unlabeled so that the patients did not know which water they were drinking. Then they were asked to eat their usual food and to drink their usual drinks, also they could drink water ad libitum after drinking the daily doses, and to have the same physical activities that they used to do in their usual daily life. They were instructed to take their medications as usual, and were told to come to test their blood sugar level at the end of the third month to get the HbA1c tested at the end of the three months of drinking the water.

Official Title
-----------------
Evaluation of Using a Nanotechnology Structured Water Magnalife® to Achieve Controlled Blood Glucose Level in Type 2 Diabetic Patients.

Conditions
-----------------
Type2 Diabetes

Intervention / Treatment
-----------------
* Dietary Supplement: Nanotechnology structured water ( Magnalife)
* Dietary Supplement: ordinary water


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Type 2 diabetic patients Exclusion Criteria: Malignancy Steroids Immunotherapy Chemotherapy Radiotherapy Chronic infections Drugs that antagonize or synergies insulin effects
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Active Comparator: Magnalife<br>the group of patients receiving the nanotechnology structured water | Dietary Supplement: Nanotechnology structured water ( Magnalife)<br>* Nanotechnology structured water ( Magnalife), is given as dietary supplement to the patients to drink it according to their weight .<br>* Other names: Magnalife;|
| Placebo Comparator: Ordinary water<br>the group of patients receiving ordinary water | Dietary Supplement: ordinary water<br>* Ordinary bottled water<br>* Other names: Bottled drinking water;|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| HbA1c | measurement of HbA1c | three months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Nanotechnology water, HbA1c, Type 2 Diabetes mellitus